Shouguang Fukang Pharmaceutical

Shouguang Fukang Pharmaceutical is a Chinese pharmaceutical manufacturing company focused primarily on small-molecule active pharmaceutical ingredients, intermediates, and selected finished-dose products. The company is best known as a large-scale producer of trimethoprim and also manufactures products such as omeprazole, sulfamethoxazole, metformin, clozapine, esomeprazole magnesium, pantoprazole sodium, and related intermediates. In addition to pharmaceuticals, it has reported business lines in bromide compounds and paper additives, including a joint venture related to paper chemicals with BASF. Available sources describe the company as operating large manufacturing facilities in Shouguang, Shandong, with GMP and other quality certifications and exports to numerous international markets. It appears to be a commercial-stage manufacturing and supply company rather than a clinical-stage innovative biotech developer.